RxDoctor Payments Data

Jacquelyn Lewis, PA

Physician Assistant · Lansing, MINPI 1386150746

Payments from drug & device makers

$9,068in general payments, 2019–2025

Across 547 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$664
  • Amgen$591
  • Pfizer$550
  • AstraZeneca$377
  • plus $5K from 51 others

What the payments were for

  • Food & beverage$9,057100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,068 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$50,723
Medicare patients
109
Services billed
1,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide53$69,188
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$67,753
EliquisApixaban56$63,435
OzempicSemaglutide32$61,157
FarxigaDapagliflozin Propanediol39$52,371
JardianceEmpagliflozin27$45,392
RybelsusSemaglutide28$44,202
RexultiBrexpiprazole20$28,029
XareltoRivaroxaban16$22,396
ProliaDenosumab13$21,522
VraylarCariprazine Hcl15$20,044
LinzessLinaclotide17$15,247
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,370
GemtesaVibegron16$11,769
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen330$5,753

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,268$105,35960 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$377$69,91764 claims
Lilly USA, LLCMounjaro$349$69,18853 claims
GSKTrelegy Ellipta$331$67,75365 claims
PfizerEliquis$550$63,43556 claims
Boehringer IngelheimJardiance$239$45,39227 claims
AbbVieVraylar, Linzess, Synthroid$1,098$36,29444 claims
Otsuka America Pharmaceutical, Inc.Rexulti$664$28,02920 claims
Johnson & JohnsonXarelto$207$22,39616 claims
AmgenProlia$591$21,52213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →